GalChimia doubles the surface of its R&D&I center in the Barcelona Science Park Blog Post

Galician company GalChimia has doubled the facility and personnel count of its R&D&I center at the Barcelona Science Park, which was opened just a year ago to accelerate its growth and internationalization strategy an initiative to share the knowledge and experience of experts in the pharmaceutical and biotech industry in the field of discovery and drug development with its clients and the scientific community. Coinciding with the inauguration of its new laboratories, the company celebrated its first “GalChimia Day”, an initiative to share the knowledge and experience of experts in the pharmaceutical and biotech industry in the field of discovery and drug development with its clients and the scientific community.

 

The MessyCheffy project won the challenge launched by the PCB, the IBEC and the IRB in the iFest Countdown Blog Post

MessyCheffy, an interactive physiotherapy game for children with muscular dystrophy, developed by the Yallow team from the University of Barcelona, has won the “Rare Diseases” challenge set by the Barcelona Science Park, the Institute for Bioengineering of Catalonia (IBEC) and the Institute for Research in Biomedicine (IRB Barcelona) as part of the iFest Countdown initiative. The young finalists of this programme presented their prototypes to a panel at the Auditorium Imagina Mediapro today at the iFest Demo Day, during an event chaired by the director of Catalunya Emprèn, Pere Condom. 

 

The call for the 2019-2020 Research in Society program is open Blog Post

Today, Monday 17 Juny the Barcelona Science Park has kicked off its 19th Research in Society programme with the opening of the pre-registration period for the experimental workshops “Discover research!” and “Do research!”. Places will be allocated to applicant schools in a draw using the list of reservation numbers.

 

The body responds to variations in light between the day and night independently of the brain Blog Post

Scientists at the Institute for Research in Biomedicine (IRB Barcelona) at PCB have revealed that although each tissue receives information from the central clock in order to coordinate its functions, each one also has the capacity to respond independently to variations in light and to detect changes in light intensity between the day and night. Published in two papers in the journal Cell, the studies confirm that this autonomy allows tissues to maintain minimal functions even when another tissue in our body is failing.

 

CataloniaBio & HealthTech and Boston MassMEDIC join forces Blog Post

CataloniaBio & HealthTech –the association of companies in the biomedicine and health arena in Catalonia, based in the Barcelona Science Park– and the Massachusetts Medical Device Industry Council (MassMEDIC), the largest association of medical technology companies in the United States, have signed an agreement to foster innovation and collaborations in business and research among their members. 

 

The BSC-IRB researcher Toni Gabaldón, vice president of the new Young Academy of Spain Blog Post

The Young Academy of Spain has been constituted today in the Ministry of Science, Innovation and Universities with the aim of representing and giving visibility to young scientists, preferably from the field of experimental sciences. One of the founding members and vice president of this new scientific institution is ICREA researcher Toni Gabaldón, with double affiliation to the Barcelona Supercomputing Center (BSC-CNS) and IRB Barcelona, leading the Comparative Genomics group.

 

The hippocampus orchestrates the cerebral process that allows us to recall memories Blog Post

For the first time in humans, researchers from the Institute for Bioengineering of Catalonia (IBEC) at the Barcelona Science Park have simultaneously recorded the brain activity of the two key areas linked to memory: the hippocampus and the neocortex. This study was made possible thanks to the voluntary participation of epilepsy patients who, due to their disease, have intracranial electrode implants. Making use of virtual reality, the participants performed spatial memory tasks. 

 

Bionure launches a crowdfunding campaign to fund the preparation the phase 2 study of BN201 Blog Post

Bionure, a biotech company specialized in neuroprotection based in the Barcelona Science Park, has launched a crowdfunding campaign through the Spanish platform of Capital Cell with the objective of raising €1.3M that will be used to finance the preparation of the phase 2 study of its neuroprotectant BN201. The campaign (multiplesmotivos.com) is part of a bridge round of €2.4M that will cover the expenses of regulatory and technical preparation of the phase 2 study.